Dysphagia
1
Pipeline Programs
4
Companies
5
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
PhagenesisUK - Manchester
2 programs1. Phagenyx® System Group PatientsN/A1 trial
Pharyngeal Electrical StimulationN/A1 trial
Active Trials
Knight TherapeuticsQC - Montréal
2 programsCytology Specimen Collection ProcedureN/A1 trial
DexamethasoneN/A1 trial
Active Trials
Alliance PharmaceuticalsUK - Wiltshire
1 programrepetitive magnetic stimulationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Phagenesis1. Phagenyx® System Group Patients
PhagenesisPharyngeal Electrical Stimulation
Alliance Pharmaceuticalsrepetitive magnetic stimulation
Knight TherapeuticsCytology Specimen Collection Procedure
Knight TherapeuticsDexamethasone
Clinical Trials (5)
Total enrollment: 138 patients across 5 trials
Phagenyx® Registry Study
Start: Sep 2025Est. completion: Sep 2036
N/ARecruiting
The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy
Start: Jun 2019Est. completion: Dec 2025
N/ARecruiting
Neurostimulation for Dysphagia in Parkinson's Disease
Start: Aug 2017Est. completion: Aug 202112 patients
N/ACompleted
Esophageal Cytology With FISH in Detecting Esophageal Cancer
Start: Feb 2014Est. completion: Dec 201550 patients
N/ACompleted
Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer
Start: Dec 2012Est. completion: Mar 201776 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 138 patients
4 companies competing in this space